Phase 1/2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS)

NCT07293546 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

FOXG1 Research Foundation